CorVel Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRVL research report →
Price Chart
About the company
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs.
- CEO
- Sarah Scott
- IPO
- 1991
- Employees
- 5,239
- HQ
- Fort Worth, TX, US
Get TickerSpark's AI analysis on CRVL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.44B
- P/E
- 37.09
- PEG
- 2.23
- P/S
- 4.40
- P/B
- 10.36
- EV/EBITDA
- 22.59
- Div Yield
- 0.00%
- Gross Margin
- 24.65%
- Op Margin
- 15.93%
- Net Margin
- 12.02%
- ROE
- 30.20%
- ROIC
- 26.21%
Latest fiscal year · YoY change
- Revenue
- $958.53M+7.0%
- Gross Profit
- $232.86M+11.0%
- Op Income
- $143.13M
- Net Income
- $110.34M+16.0%
- EPS
- $2.15+16.2%
- OCF Growth
- +22.2%
- FCF Growth
- +20.4%
- 52W High
- $90.71
- 52W Low
- $44.83
- 50D MA
- $79.63
- 200D MA
- $63.99
- Beta
- 1.08
- RSI (14)
- 65
- Avg Volume
- 195.34K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
CorVel reported solid fiscal 2026 growth, with revenue, EPS, margins, and cash flow all improving, while management pointed to a stronger bookings pipeline and new payer programs as the next growth drivers.· May 20, 2026
- March quarter revenue rose 7% to $249 million and EPS increased to $0.61 from $0.51 a year ago.
- Fiscal 2026 revenue was $959 million, up 7%, and EPS was $2.14, up 17%.
- Operating margin improved to 15% for fiscal 2026, and G&A fell to 9.4% of revenue in the fourth quarter from 10.6% a year ago.
- New bookings in the March quarter increased 56% year over year, with RFP activity up 20%, supporting the pipeline.
- Management said four large payer programs are launching in 2026, including two new multiyear partnerships with top 10 national payers.
CorVel reported March quarter revenue of $249 million, up 7% from $232 million in the prior-year quarter, and EPS of $0.61 versus $0.51. For fiscal 2026, revenue was $959 million, up 7% from $896 million, and EPS was $2.14 versus $1.83. Net income for fiscal 2026 was $110 million, up nearly 14% from $95 million, and operating margin was 15%, an improvement of 1.4 points. Fourth-quarter G&A decreased by $1.3 million year over year and fell to 9.4% of revenue from 10.6%. Looking ahead, management did not give a numeric revenue or EPS guide, but said multiyear bookings are expected to contribute meaningfully to revenue and profit growth in the back half of the calendar year, with prepaid solutions realizing revenue in 1 to 2 months versus 6 months or longer for postpaid.
Michael Combs emphasized that CorVel is benefiting from industry demand for payment accuracy, cost containment, and more proactive claims management. He said CERIS is well aligned with this shift through integrated prepay and postpay solutions, and highlighted four large payer programs launching in 2026, including two new multiyear partnerships with top 10 national payers. His tone was confident and strategic, framing AI, automation, and integrated data as the main enablers of future scalability and differentiation.
Brian Nichols said the year benefited from revenue and profit growth in Network Solutions, including a timing-related boost from accelerated post-payment recoveries that added $0.02 of EPS. He noted fourth-quarter G&A declined by $1.3 million, helping reduce G&A to 9.4% of revenue, and said the fiscal 2026 operating margin reached 15%. He also highlighted strong capital returns and liquidity: 872,744 shares were repurchased in fiscal 2026 for $56 million, cash at year-end was $233 million, free cash flow was $66 million, and the company remains debt-free. DSO improved to 37 days, down 4 days year over year.
There was no analyst Q&A; the call ended with no questions. As a result, the only forward-looking commentary came from management’s prepared remarks, which focused on growth from large payer program launches, new bookings, and AI-enabled productivity gains. Management also said personnel levels are expected to normalize as deployments mature and automation expands.
The bull case is that CorVel is seeing strong commercial momentum, with bookings up 56% and RFPs up 20%, while several large multiyear payer programs are just beginning to ramp. Management also sees AI and automation improving productivity and operating leverage over time, supported by a debt-free balance sheet and solid cash generation.
The main risks raised were timing and execution: some fiscal 2026 results benefited from onetime events and accelerated recoveries, and management said personnel levels increased for implementation activity before they normalize. The company also flagged a tougher operating environment with higher claims severity, medical costs, regulatory complexity, and cybersecurity risk, all of which could pressure execution.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 61.1%
- Shares Outstanding
- 50.35M
- Float Shares
- 30.76M
of shares held by institutions
291 13F filers
Buy/sell ratio 0.71. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 5.17M | ▲ 30.87K |
| Kayne Anderson Rudnick Investment Management LLC | 4.39M | ▼ 164.03K |
| Vanguard Group Inc | 3.24M | ▼ 46.68K |
| Vanguard Portfolio Management LLC | 1.69M | ▼ 27.10K |
| Renaissance Technologies LLC | 1.45M | ▼ 82.70K |
| State Street Corp | 1.30M | ▲ 13.19K |
| Vanguard Capital Management LLC | 1.30M | ▼ 554 |
| Dimensional Fund Advisors LP | 1.15M | ▲ 10.36K |
| Geode Capital Management, LLC | 1.01M | ▼ 4.86K |
| Morgan Stanley | 603.36K | ▼ 52.34K |
| Algert Global LLC | 471.63K | ▲ 88.21K |
| Wells Fargo & Company/Mn | 416.05K | ▼ 37.10K |
Held by 430 ETFs
Biggest fund positions in CRVL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 16, 26 | Bertels Mark E. | other | 3,000 |
| Nov 16, 26 | Bertels Mark E. | other | 1,815 |
| Nov 16, 26 | Bertels Mark E. | other | 3,000 |
| Nov 16, 26 | Bertels Mark E. | other | 1,032 |
| Nov 16, 26 | Bertels Mark E. | sell | 1,032 |
| Nov 16, 26 | Bertels Mark E. | other | 1,815 |
| Nov 16, 26 | Bertels Mark E. | other | 1,032 |
| Nov 13, 26 | Yoss Jennifer | other | 2,100 |
| Nov 13, 26 | Yoss Jennifer | sell | 2,100 |
| Nov 13, 26 | Yoss Jennifer | other | 2,100 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CRVL coverage
Recent articles, reports, and earnings notes.
No research on CRVL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRVL report →CorVel Announces Revenues and Earnings
globenewswire.com · Nov 3
Reviewing Guardant Health (NASDAQ:GH) & CorVel (NASDAQ:CRVL)
defenseworld.net · Sep 28
CorVel Expands Managed Care Connectivity with the CareMC® Extension for Guidewire ClaimCenter
globenewswire.com · Sep 22
Critical Comparison: Hinge Health (NYSE:HNGE) & CorVel (NASDAQ:CRVL)
defenseworld.net · Sep 22
Head to Head Analysis: CorVel (NASDAQ:CRVL) versus Wellgistics Health (NASDAQ:MEDS)
defenseworld.net · Sep 3
Assenagon Asset Management S.A. Sells 95,906 Shares of CorVel Corp. $CRVL
defenseworld.net · Aug 12
CorVel Corporation (CRVL) Q1 2027 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Aug 5
CorVel Q1 Earnings Call Highlights
marketbeat.com · Aug 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.